Filing Details
- Accession Number:
- 0001062993-23-004066
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-17 16:45:18
- Reporting Period:
- 2023-02-15
- Accepted Time:
- 2023-02-17 16:45:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1227636 | Neuronetics Inc. | STIM | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1758584 | Andrew William Macan | C/O Neuronetics, Inc 3222 Phoenixville Pike Malvern PA 19355 | Evp, Gc, Cco And Cs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-02-15 | 11,974 | $5.90 | 411,583 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-16 | 11,044 | $5.91 | 400,539 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award.
- The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $5.81 to $6.00. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $5.72 to $6.01. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
